Page last updated: 2024-08-18

cyclohexanol and carbostyril

cyclohexanol has been researched along with carbostyril in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's6 (37.50)29.6817
2010's9 (56.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frisvad, JC; Rassing, BR; Samson, RA; Stark, J; van der Horst, MI; van Rijn, FT1
Kamatani, A; Overman, LE1
Blashki, G; Keks, N1
Carter, WG; Shillcutt, SD1
Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH1
Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K1
Kyomen, HH; Whitfield, TH1
Butters, MA; Dew, MA; Driscoll, HC; Lenze, EJ; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Sheffrin, M1
Baker, RA; Berman, RM; Carlson, BX; Eudicone, JM; Mankoski, R; Nelson, JC; Pikalov, A; Tran, QV1
Bolognini, D; Cascio, MG; Corelli, F; Di Marzo, V; Maione, S; Palazzo, E; Pasquini, S; Pertwee, RG1
Bundgaard, C; Garmer, M; Jensen, CJ1
Rittmannsberger, H; Werl, R1
Dou, J; Hu, X; Liu, J; Shen-Tu, J; Wu, G; Wu, L; Xu, Q; Zhou, H1
Begley, AE; Blumberger, D; Butters, M; Dew, MA; Joel, I; Lenze, EJ; Mazumdar, S; Mulsant, BH; Reynolds, CF1
Jiao, P; Liu, H; Xue, W; Yao, X1
Begley, A; Butters, MA; Koenig, AM; Ogbagaber, S; Reynolds, CF; Wahed, AS1

Trials

6 trial(s) available for cyclohexanol and carbostyril

ArticleYear
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2

    Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment

2008
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:4

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult

2010
Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:2

    Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Feasibility Studies; Female; Humans; Male; Personality Inventory; Pilot Projects; Piperazines; Quinolones; Thiophenes; Venlafaxine Hydrochloride

2009
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.
    Journal of affective disorders, 2010, Volume: 120, Issue:1-3

    Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride

2010
Development of a simple LC-MS/MS method for determination of rebamipide in human plasma and its application to a bioequivalence study.
    Die Pharmazie, 2012, Volume: 67, Issue:11

    Topics: Alanine; Anti-Ulcer Agents; Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclohexanols; Female; Half-Life; Humans; Male; Quality Control; Quinolones; Reproducibility of Results; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Venlafaxine Hydrochloride; Young Adult

2012
Dynamic prediction of treatment response in late-life depression.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:2

    Topics: Age of Onset; Aged; Aged, 80 and over; Aripiprazole; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quinolones; Remission Induction; Severity of Illness Index; Signal Detection, Psychological; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride

2014

Other Studies

10 other study(ies) available for cyclohexanol and carbostyril

ArticleYear
Penicillium discolor, a new species from cheese, nuts and vegetables.
    Antonie van Leeuwenhoek, 1997, Volume: 72, Issue:2

    Topics: Benzodiazepinones; Camphanes; Cheese; Culture Media; Cyclohexanols; Cyclohexanones; Food Microbiology; Hydroxyquinolines; Indole Alkaloids; Indoles; Microscopy, Electron, Scanning; Naphthols; Nuts; Penicillium; Pigments, Biological; Quinolones; Sucrose; Vegetables

1997
A new asymmetric synthesis of trans-hydroisoquinolones.
    Organic letters, 2001, Apr-19, Volume: 3, Issue:8

    Topics: Carbon; Cations; Cyclohexanols; Models, Chemical; Oxygen; Quinolones

2001
The acutely psychotic patient--assessment and initial management.
    Australian family physician, 2006, Volume: 35, Issue:3

    Topics: Acute Disease; Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Cyclohexanols; Female; Humans; Male; Physicians, Family; Piperazines; Practice Guidelines as Topic; Psychotic Disorders; Quinolones; Referral and Consultation; Risk Assessment; Venlafaxine Hydrochloride

2006
Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:8

    Topics: Antipsychotic Agents; Aripiprazole; Cyclohexanols; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Skin; Treatment Outcome; Venlafaxine Hydrochloride

2006
Psychosis in the elderly.
    The American journal of psychiatry, 2009, Volume: 166, Issue:2

    Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Combined Modality Therapy; Comorbidity; Cyclohexanols; Delirium; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Memantine; Nootropic Agents; Piperazines; Psychotherapy; Psychotic Disorders; Quinolones; Risk Factors; Treatment Outcome; Venlafaxine Hydrochloride

2009
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists.
    Pharmacological research, 2010, Volume: 61, Issue:4

    Topics: Analgesics; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Drug Inverse Agonism; Formaldehyde; Guanosine 5'-O-(3-Thiotriphosphate); Mice; Molecular Structure; Pain; Quinolones; Radioligand Assay; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2010
Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:3

    Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Citalopram; Cyclohexanols; Gene Knockout Techniques; Genotype; Mice; Piperazines; Quinolones; Rats; Risperidone; Species Specificity; Venlafaxine Hydrochloride

2012
Does aripiprazole protect from serotonin syndrome?
    Psychiatria Danubina, 2012, Volume: 24, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tremor; Venlafaxine Hydrochloride; Young Adult

2012
Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598.
    Antiviral research, 2014, Volume: 104

    Topics: Antiviral Agents; Benzothiadiazines; Binding Sites; Cyclohexanols; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Hydrogen Bonding; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Binding; Quinolones; Thiophenes; Viral Nonstructural Proteins

2014
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning.
    The Journal of clinical psychiatry, 2014, Volume: 75, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysfunction; Cyclohexanols; Dementia; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride

2014